Jumpei Taguchi - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

Jumpei Taguchi

Showing results (21-30 of 23) with videos related to

Pageof 3

Sort By:

You have reached the last page of results.This site can display upto 23 results.

Nature Communications|August 20, 2021

DMRT1-mediated reprogramming drives development of cancer resembling human germ cell tumors with features of totipotencyJumpei Taguchi, Hirofumi Shibata, Mio Kabata, et al.

Proceedings of the National Academy of Sciences of the United States of America|August 7, 2025

Discovery and development of an oral analgesic targeting the α2B adrenoceptorMasayasu Toyomoto, Takashi Kurihara, Takayuki Nakagawa, et al.

Journal of Controlled Release : Official Journal of the Controlled Release Society|October 13, 2025

Claudin 5-binding small molecule transiently opens the blood-brain barrier and safely enhances brain drug deliverySaito Inoue, Keisuke Shirakura, Atsuya Shirono, et al.

Pageof 3

Search research articles

Showing results (21-30 of 23) with videos related to

Sort By:

Pageof 3

You have reached the last page of results.This site can display upto 23 results.

Nature Communications|August 20, 2021

DMRT1-mediated reprogramming drives development of cancer resembling human germ cell tumors with features of totipotencyJumpei Taguchi, Hirofumi Shibata, Mio Kabata, et al.

Proceedings of the National Academy of Sciences of the United States of America|August 7, 2025

Discovery and development of an oral analgesic targeting the α2B adrenoceptorMasayasu Toyomoto, Takashi Kurihara, Takayuki Nakagawa, et al.

Journal of Controlled Release : Official Journal of the Controlled Release Society|October 13, 2025

Claudin 5-binding small molecule transiently opens the blood-brain barrier and safely enhances brain drug deliverySaito Inoue, Keisuke Shirakura, Atsuya Shirono, et al.

Pageof 3